Clinical Trial Update: Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating a CAR-T cell therapy that targets carcinoembryonic antigen (CEA) in patients with advanced lung cancer; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• CEA-targeted CAR-T cell therapy (CAR-T cell therapy targeting carcinoembryonic antigen (CEA))

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Advanced Lung Cancer | Phase 1 | Status: RECRUITING